Ad
related to: maker of zocor and fosamax free drug class for dogs prices lookup form
Search results
Results From The WOW.Com Content Network
Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]
[7] [8] It is considered to be highly effective in dogs, and has been established as safe for at least short-term use. [ 9 ] [ 10 ] [ 11 ] Its efficacy equals that of prednisolone at first, though oclacitinib has been found to be more effective in the short term in terms of itchiness and dermatitis, long term safety is unknown. [ 12 ]
This article lists veterinary pharmaceutical drugs alphabetically by name. Many veterinary drugs have more than one name and, therefore, the same drug may be listed more than once. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name
Simvastatin, sold under the brand name Zocor among others, is a statin, a type of lipid-lowering medication. [4] It is used along with exercise, diet, and weight loss to decrease elevated lipid levels. [4]
Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. [4] It is taken by mouth. [ 4 ] Use is often recommended together with vitamin D , calcium supplementation , and lifestyle changes.
The company’s lawsuits cite the Food and Drug Administration’s Adverse Event Reporting System, which showed that as of Sept. 20, there have been 281 cases of adverse events associated with ...
GLP-1 drugs like Ozempic and Wegovy were brought on the market to treat Type-2 diabetes, but have found mass appeal thanks to their ability to help users lose weight.
A Department of Health and Human Services report in February found that in 2022, prices of all drugs in the U.S. — both brand name and generic — were nearly three time as high as in other ...